Sunday, November 13, 2022
- 9:00AM-10:30AM
-
Abstract Number: 0828
Impact of Hospitalization on Clinical Outcomes in Patients with Connective Tissue Disease-associated Interstitial Lung Disease
Miscellaneous Rheumatic and Inflammatory Diseases Poster II- 9:00AM-10:30AM
-
Abstract Number: 0984
Impact of Hydroxychloroquine on Interferon Pathway Expression of SLE Phenotypic Subsets in the Absence of Background Medications
SLE – Treatment Poster II- 9:00AM-10:30AM
-
Abstract Number: 0925
Impact of Initiating Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs on Pain Medication Use in Patients with Rheumatoid Arthritis
RA – Treatment Poster II- 9:00AM-10:30AM
-
Abstract Number: 0934
Impact of Tapering Targeted Therapy on Disease Activity Is Different Based on Concomitant Methotrexate Use in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study
RA – Treatment Poster II- 9:00AM-10:30AM
-
Abstract Number: 0862
Impact of the COVID-19 Pandemic on the Management of Juvenile Idiopathic Arthritis: An Analysis of National United States Administrative Claims Data
Pediatric Rheumatology – Clinical Poster I: JIA- 9:00AM-10:30AM
-
Abstract Number: 1006
Impact of Uric Acid Levels on Clinical and Radiographic Characteristics in Psoriatic Arthritis and Response to Secukinumab: A Pooled “Post Hoc” Analysis from Five Phase 3 Studies
Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster II- 9:00AM-10:30AM
-
Abstract Number: 0794
Impact of Vaccination on Post-acute Sequelae of SARS CoV-2 Infection in Patients with Rheumatic Diseases
Infection-related Rheumatic Disease Poster- 9:00AM-10:30AM
-
Abstract Number: 0986
Impact of Weight and Race on Renal Response to Cyclophosphamide in the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study (ACCESS)
SLE – Treatment Poster II- 9:00AM-10:30AM
-
Abstract Number: 1040
Impact of Weight and Sex on Long-term Persistence to Secukinumab Treatment in Patients with Active Psoriatic Arthritis or Ankylosing Spondylitis
Spondyloarthritis Including PsA – Treatment Poster II: Mixed- 9:00AM-10:30AM
-
Abstract Number: 0711
Improvement in Excess Mortality in Patients with Rheumatoid Arthritis over the Last Two Decades: A Danish Population-based Matched Cohort Study
Epidemiology and Public Health Poster I- 9:00AM-10:30AM
-
Abstract Number: 0730
Improving Mental Health Services in Children and Adolescents with Systemic Lupus Erythematosus by Establishing a Mental Health Care Navigator
Health Services Research Poster II- 9:00AM-10:30AM
-
Abstract Number: 0804
Incidence and Risk Factors of Active Tuberculosis in Patients with Rheumatic Diseases Complicated with Tuberculosis Infection: A Multicenter Prospective Cohort Study
Infection-related Rheumatic Disease Poster- 9:00AM-10:30AM
-
Abstract Number: 0886
Incidence of Depression and Anxiety in Rheumatoid Arthritis Patients over Three Decades: A Population-Based Study
RA – Diagnosis, Manifestations, and Outcomes Poster II- 9:00AM-10:30AM
-
Abstract Number: 0861
Incidence of Juvenile Idiopathic Arthritis During the COVID-19 Pandemic: An Analysis of National United States Administrative Claims Data